Submission Details
| 510(k) Number | K132465 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 07, 2013 |
| Decision Date | September 09, 2013 |
| Days to Decision | 33 days |
| Submission Type | Special |
| Review Panel | Microbiology (MI) |
| Summary | Statement |
K132465 is an FDA 510(k) clearance for the BIOSIGN FLU A + B, STATUS FLU A & B, a Devices Detecting Influenza A, B, And C Virus Antigens (Class II — Special Controls, product code PSZ), submitted by Princeton BioMeditech Corp. (Monmouth Junction, US). The FDA issued a Cleared decision on September 9, 2013, 33 days after receiving the submission on August 7, 2013. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3328.
| 510(k) Number | K132465 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 07, 2013 |
| Decision Date | September 09, 2013 |
| Days to Decision | 33 days |
| Submission Type | Special |
| Review Panel | Microbiology (MI) |
| Summary | Statement |
| Product Code | PSZ — Devices Detecting Influenza A, B, And C Virus Antigens |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3328 |
| Definition | An Influenza Virus Antigen Detection Test System Is A Device Intended For The Qualitative Detection Of Influenza Viral Antigens Directly From Clinical Specimens In Patients With Signs And Symptoms Of Respiratory Infection. |